| 1 | survey | 10,943 |
| 2 | fieldwork | 85 |
| 3 | c30 | 57 |
| 4 | poll | 22 |
| 5 | quasi-experiment | 10 |
| 6 | call-out | 6 |
| 7 | painter | 6 |
| 8 | study-2 | 5 |
| 9 | algo-2 | 3 |
| 10 | breast-q | 3 |
| 11 | core-30 | 3 |
| 12 | helipad | 3 |
| 13 | medline-search | 3 |
| 14 | row-column | 3 |
| 15 | tyumen | 3 |
| 16 | aminopyrimidine | 2 |
| 17 | consignment | 2 |
| 18 | fcz-kt | 2 |
| 19 | lc-43 | 2 |
| 20 | purkynje | 2 |
| 21 | serosurvey | 2 |
| 22 | stop-study | 2 |
| 23 | studywas | 2 |
| 24 | -2·31 | 1 |
| 25 | 3.edition | 1 |
| 26 | 96/518 | 1 |
| 27 | burden-of-disease | 1 |
| 28 | characteristics.there | 1 |
| 29 | civiq-14 | 1 |
| 30 | concomittantly | 1 |
| 31 | cr300 | 1 |
| 32 | crossbeam | 1 |
| 33 | discussiondetailing | 1 |
| 34 | electroretinogram-saturated | 1 |
| 35 | elispots | 1 |
| 36 | eors | 1 |
| 37 | iop±sd | 1 |
| 38 | mona | 1 |
| 39 | postreading | 1 |
| 40 | score-total | 1 |
| 41 | stroke-sub-study | 1 |
| 42 | study-depression | 1 |
| 43 | survey-experiment | 1 |
| 44 | survey/resurvey | 1 |
| 45 | surveys- | 1 |
| 46 | teams/sites | 1 |
| 47 | time-history | 1 |
| 48 | training/correction | 1 |
| 49 | tvr-resistance | 1 |
| 50 | €184.44 | 1 |
| 1 | -2·31 | 1 |
| 2 | 3.edition | 1 |
| 3 | 96/518 | 1 |
| 4 | algo-2 | 3 |
| 5 | aminopyrimidine | 2 |
| 6 | breast-q | 3 |
| 7 | burden-of-disease | 1 |
| 8 | c30 | 57 |
| 9 | call-out | 6 |
| 10 | characteristics.there | 1 |
| 11 | civiq-14 | 1 |
| 12 | concomittantly | 1 |
| 13 | consignment | 2 |
| 14 | core-30 | 3 |
| 15 | cr300 | 1 |
| 16 | crossbeam | 1 |
| 17 | discussiondetailing | 1 |
| 18 | electroretinogram-saturated | 1 |
| 19 | elispots | 1 |
| 20 | eors | 1 |
| 21 | fcz-kt | 2 |
| 22 | fieldwork | 85 |
| 23 | helipad | 3 |
| 24 | iop±sd | 1 |
| 25 | lc-43 | 2 |
| 26 | medline-search | 3 |
| 27 | mona | 1 |
| 28 | painter | 6 |
| 29 | poll | 22 |
| 30 | postreading | 1 |
| 31 | purkynje | 2 |
| 32 | quasi-experiment | 10 |
| 33 | row-column | 3 |
| 34 | score-total | 1 |
| 35 | serosurvey | 2 |
| 36 | stop-study | 2 |
| 37 | stroke-sub-study | 1 |
| 38 | study-2 | 5 |
| 39 | study-depression | 1 |
| 40 | studywas | 2 |
| 41 | survey | 10,943 |
| 42 | survey-experiment | 1 |
| 43 | survey/resurvey | 1 |
| 44 | surveys- | 1 |
| 45 | teams/sites | 1 |
| 46 | time-history | 1 |
| 47 | training/correction | 1 |
| 48 | tvr-resistance | 1 |
| 49 | tyumen | 3 |
| 50 | €184.44 | 1 |
| 1 | surveys- | 1 |
| 2 | cr300 | 1 |
| 3 | core-30 | 3 |
| 4 | c30 | 57 |
| 5 | -2·31 | 1 |
| 6 | algo-2 | 3 |
| 7 | study-2 | 5 |
| 8 | lc-43 | 2 |
| 9 | civiq-14 | 1 |
| 10 | €184.44 | 1 |
| 11 | 96/518 | 1 |
| 12 | mona | 1 |
| 13 | helipad | 3 |
| 14 | electroretinogram-saturated | 1 |
| 15 | iop±sd | 1 |
| 16 | tvr-resistance | 1 |
| 17 | purkynje | 2 |
| 18 | aminopyrimidine | 2 |
| 19 | characteristics.there | 1 |
| 20 | burden-of-disease | 1 |
| 21 | postreading | 1 |
| 22 | discussiondetailing | 1 |
| 23 | medline-search | 3 |
| 24 | fieldwork | 85 |
| 25 | score-total | 1 |
| 26 | poll | 22 |
| 27 | crossbeam | 1 |
| 28 | tyumen | 3 |
| 29 | row-column | 3 |
| 30 | study-depression | 1 |
| 31 | training/correction | 1 |
| 32 | 3.edition | 1 |
| 33 | breast-q | 3 |
| 34 | painter | 6 |
| 35 | studywas | 2 |
| 36 | teams/sites | 1 |
| 37 | eors | 1 |
| 38 | elispots | 1 |
| 39 | fcz-kt | 2 |
| 40 | quasi-experiment | 10 |
| 41 | survey-experiment | 1 |
| 42 | consignment | 2 |
| 43 | call-out | 6 |
| 44 | stroke-sub-study | 1 |
| 45 | stop-study | 2 |
| 46 | survey | 10,943 |
| 47 | survey/resurvey | 1 |
| 48 | serosurvey | 2 |
| 49 | concomittantly | 1 |
| 50 | time-history | 1 |